Patents by Inventor Caterina Fattorusso

Caterina Fattorusso has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL 4-AMINO-QUINOLINE DERIVATIVES USEFUL AS ANTI-MALARIA DRUGS
    Publication number: 20100093726
    Abstract: The present invention relates to clotrimazole/quinoline hybrids useful as active ingredients of anti-malaria drugs. The compounds show a remarkable in vitro biological activity especially against the chloroquine-resistant Plasmodium falciparum strains and in vivo activity against P. berghei.
    Type: Application
    Filed: February 18, 2008
    Publication date: April 15, 2010
    Applicant: Giuseppe CAMPIANI
    Inventors: Giuseppe Campiani, Sandra Gemma, Caterina Fattorusso, Gagan Kukreja, Bhupendra Prasad Joshi, Stefania Butini, Marco Persico, Salvator Sanna Coccone, Matteo Bernetti
  • ARYL PIPERAZINE DERIVATIVES USEFUL FOR THE TREATMENT OF NEUROPSYCHIATRY DISORDERS
    Publication number: 20100087445
    Abstract: This invention provides novel aryl piperazine derivatives represented by Formula (I) having medical utility, in particular as modulators of dopamine and serotonin receptors, preferably the D3, 5HT1A and 5-HT2A receptor subtypes, and in particular useful for the treatment of neuropsychiatric disorders, incl. schizophrenia.
    Type: Application
    Filed: October 12, 2007
    Publication date: April 8, 2010
    Applicant: Universita degli Studi di Siena
    Inventors: Giuseppe Campiani, Stefania Butini, Caterina Fattorusso, Silvia Franceschini, Irene Zia Thale, Karin Sandager Nielsen, Jørgen Scheel-Krüeger, Lars Siim Madsen
  • Novel Aryl Piperazine Derivatives With Medical Utility
    Publication number: 20090238761
    Abstract: This invention provides novel aryl piperazine derivatives having medical utility, in particular as modulators of dopamine and serotonin receptors, preferably the D3, D2-like and 5-HT2 receptor subtypes, and in particular useful for the treatment of neuropsychiatric disorders incl. schizophrenia.
    Type: Application
    Filed: January 2, 2006
    Publication date: September 24, 2009
    Applicant: Universita Degli Studi Di Siena
    Inventors: Giuseppe Campiani, Stefania Butini, Caterina Fattorusso, Francesco Trotta, Silvia Franceschini, Meri De Angelis, Karin Sandager Nielsen